SCHEMBL201538

SCHEMBL201538

CC=COCc1ccccc1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 2/20 0.48
IDO1 P14902 1/20 0.44
AGXT P21549 1/20 0.43
ALDH1A1 P00352 3/20 0.42
L3MBTL1 Q9Y468 3/20 0.41
MAPT P10636 2/20 0.41
MAPK1 P28482 2/20 0.41
TDP1 Q9NUW8 2/20 0.41
TP53 P04637 1/20 0.39
CA1 P00915 2/20 0.38
CA2 P00918 2/20 0.38
CA9 Q16790 2/20 0.38
SLC6A2 P23975 2/20 0.38
SLC6A3 Q01959 2/20 0.38
LMNA P02545 1/20 0.38
CYP1A2 P05177 1/20 0.38
PTGS1 P23219 1/20 0.38
CYP2C19 P33261 1/20 0.38
PTGS2 P35354 1/20 0.38
HIF1A Q16665 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL201537 1.00 TSHR (0.48) TSHRIDO1AGXTALDH1A1L3MBTL1
SCHEMBL6731394 1.00 TSHR (0.48) TSHRIDO1AGXTALDH1A1L3MBTL1
SCHEMBL29284778 0.89 TDP1 (0.43) TSHRIDO1AGXTALDH1A1L3MBTL1
SCHEMBL27509183 0.85 TSHR (0.57) TSHRIDO1AGXTALDH1A1L3MBTL1
Phosphoric Acid Monomethyl Ester SCHEMBL6825269 0.84 TSHR (0.47) TSHRALDH1A1RAB9A
SCHEMBL58206 0.81 TSHR (0.52) TSHRIDO1AGXTALDH1A1L3MBTL1
SCHEMBL16594360 0.80 TSHR (0.46) TSHRIDO1AGXTALDH1A1L3MBTL1
SCHEMBL16594361 0.80 TSHR (0.46) TSHRIDO1AGXTALDH1A1L3MBTL1
SCHEMBL11798275 0.79 TSHR (0.50) TSHRIDO1AGXTALDH1A1L3MBTL1
SCHEMBL7717208 0.78 IDO1 (0.46) TSHRIDO1AGXTALDH1A1L3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 171 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4360609-A VINYLAROMATIC POLYMER, ACTIVE ALLYL OR BENZYL CARBON, ARYLSULFONATE CATALYST THE DOW CHEMICAL COMPANY (US) 1982-11-23 US claimed
CN-117940438-A Heterocyclic compounds as MAP4K1 inhibitors 缆图药品公司 2024-04-26 CN disclosed
CN-115043966-B Main catalyst and catalyst for preparing ultra-high molecular weight polypropylene, preparation method and application 上海化工研究院有限公司 2023-11-28 CN disclosed
CN-115043966-A Main catalyst and catalyst for preparing ultrahigh molecular weight polypropylene, preparation method and application 上海化工研究院有限公司 2022-09-13 CN disclosed
CN-107285998-B Preparation method of 1- (4-chlorphenyl) -2-cyclopropyl-1-acetone 江苏剑牌农化股份有限公司 2021-05-25 CN disclosed
CN-107285998-B Preparation method of 1- (4-chlorphenyl) -2-cyclopropyl-1-acetone 江苏剑牌农化股份有限公司 2021-05-25 CN disclosed
WO-2021070491-A1 PHOTOCURABLE COMPOSITION FOR NANOIMPRINTING サンアプロ株式会社 2021-04-15 WO disclosed
US-10787576-B2 Method for the preparation of a coating comprising oligomeric alkynes ÉCOLE POLYTECHNIQUE FÉDÉRALE DE LAUSANNE (EPFL) EPFL-TTO (CH) 2020-09-29 US disclosed
EP-3599239-A1 METAL ORGANIC FRAMEWORKS AND METHODS FOR USING THEREOF Ecole Polytechnique Federale De Lausanne (EPFL) EPFL-TTO (CH) 2020-01-29 EP disclosed
CN-109336952-A Novel nuclear magnetic contrast lipid capable of being released under light control and preparation method thereof 大连理工大学 2019-02-15 CN disclosed
CN-86105877-A 6-methyl-3,4-dihydro-1,2,3-oxygen thiazine-4-ketone 2, the preparation of 2-dioxide and purification process thereof 1987-03-04 CN disclosed
US-4638063-A Process for the preparation of 6-methyl-3,4-dihydro-1,2,3-oxathiazin-4-one 2,2-dioxide and its non-toxic salts HOECHST AKTIENGESELLSCHAFT (DE) 1987-01-20 US disclosed
CN-85104278-A A kind of preparation 6-methyl-3,4-dihydro-1,2,3-thiazine-4-ketone 2, the method for 2-dioxide and nontoxicity salt thereof 1986-12-03 CN disclosed
CN-85104277-A Process for preparing 6-methyl-3, 4-dihydro-1, 2, 3-thiazin-4-one 2, 2-dioxide and its non-toxic salts, and process for preparing acetoacetamide-N-sulfonic acid 1986-12-03 CN disclosed
US-4625024-A Process for the preparation of 6-methyl-3,4-dihydro-1,2,3-oxathiazin-4-one 2,2-dioxide and its non-toxic salts HOECHST AKTIENGESELLSCHAFT (DE) 1986-11-25 US disclosed
US-4607100-A Process for the preparation of 6-methyl-3,4-dihydro-1,2,3-oxathiazin-4-one 2,2-dioxide and its non-toxic salts HOECHST AKTIENGESELLSCHAFT (DE) 1986-08-19 US disclosed
EP-0173082-A1 Process for the preparation of 6-methyl-3,4-dihydro-1,2,3-oxathiazin-4-one-2,2-dioxide and its non-toxic salts HOECHST AKTIENGESELLSCHAFT (DE) 1986-03-05 EP disclosed
US-4563521-A Process for the preparation of 6-methyl-3,4-dihydro-1,2,3-oxathiazin-4-one 2,2-dioxide and its non-toxic salts HOECHST AKTIENGESELLSCHAFT (DE) 1986-01-07 US disclosed
EP-0159516-A1 Method for the preparation of 6-methyl-3,4-dihydro-1,2,3-oxathiazin-4-one-2,2-dioxide and its non-toxic salts HOECHST AKTIENGESELLSCHAFT (DE) 1985-10-30 EP disclosed
EP-0155634-A2 Process for the preparation of 6-methyl-3,4-dihydro-1,2,3-oxathiazin-4-one 2,2-dioxide and of its non-toxic salts, as well as of acetoacetamide-N-sulfonic acid occurring as an intermediary in this process, and its salts HOECHST AKTIENGESELLSCHAFT (DE) 1985-09-25 EP disclosed